FOLFOX and intensified split-course chemoradiation as initial treatment for rectal cancer with synchronous metastases.

about

FOLFOX and intensified split-course chemoradiation as initial treatment for rectal cancer with synchronous metastases.

Item

http://www.wikidata.org/entity/Q50673731

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

FOLFOX and intensified split-c ...... r with synchronous metastases.

@en

FOLFOX and intensified split-c ...... r with synchronous metastases.

@nl

type

Item

label

FOLFOX and intensified split-c ...... r with synchronous metastases.

@en

FOLFOX and intensified split-c ...... r with synchronous metastases.

@nl

prefLabel

FOLFOX and intensified split-c ...... r with synchronous metastases.

@en

FOLFOX and intensified split-c ...... r with synchronous metastases.

@nl

P1476

FOLFOX and intensified split-c ...... r with synchronous metastases.

@en

P2093

A Heriot

http://www.w3.org/2001/XMLSchema#string

J Chu

http://www.w3.org/2001/XMLSchema#string

J McKendrick

http://www.w3.org/2001/XMLSchema#string

M Bressel

http://www.w3.org/2001/XMLSchema#string

M Jefford

http://www.w3.org/2001/XMLSchema#string

M Michael

http://www.w3.org/2001/XMLSchema#string

M Steel

http://www.w3.org/2001/XMLSchema#string

P Cooray

http://www.w3.org/2001/XMLSchema#string

S Chander

http://www.w3.org/2001/XMLSchema#string

S Ngan

http://www.w3.org/2001/XMLSchema#string

P2860

Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer

Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status

Differences in survival between colon and rectal cancer from SEER data.

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study.

Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer.

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

P304

646-652

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/0284186X.2017.1296584

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28301974

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy